Resumo

SANCHEZ-DE-CASTRO, M; GARCIA-CEREZUELA, MD; GARCIA-LUQUE, A  e  APARICIO-HERNANDEZ, R. Positive assessment of drugs: July and October 2020. Sanid. Mil. [online]. 2020, vol.76, n.4, pp.239-244.  Epub 12-Abr-2021. ISSN 1887-8571.  https://dx.doi.org/10.4321/s1887-85712020000400006.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in July and October 2020, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Acalabrutinib (Calquence®); Amikacina (Arikayce Liposomal®); Avapritinib (Ayvakyt®); Belantamab Mafodotin (Blenrep®); Crizanlizumab (Adakveo®); Dapivirina (Dapivirine®); Filgotinib (Jyseleca®); Obiltoxaximab (Obiltoxaximab Sfl®); meningococcal group A, C, W and Y conjugate vaccine (Menquadfi®); Quadrivalent Influenza Vaccine (recombinant, prepared in cell culture) (Supemtek®).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )